Determination of the α/β Ratio for the Normal Liver on the Basis of Radiation-induced Hepatic Toxicities in Patients with Hepatocellular Carcinoma

Overview

Journal Radiat Oncol

Publisher Biomed Central

Specialties Oncology
Radiology

Date 2013 Mar 19

PMID 23497395

Citations 17

Authors

Seok Hyun Son

Hong Seok Jang

Hyochun Lee

Byung Ock Choi

Young Nam Kang

Jeong Won Jang

Seung Kew Yoon

Chul Seung Kay

Affiliations

Soon will be listed here.

Abstract

Background: The purpose of this study was to determine the α/β ratio for normal liver with hepatitis by analyzing the toxicity data from patients with unresectable hepatocellular carcinoma treated with helical tomotherapy.

Methods: Between March 2006 and February 2012, 98 patients were eligible for this study. 66 patients received 45-50 Gy in 4.5-5 Gy fractions (Group A) and 32 patients received 36-60 Gy in 2.5-3 Gy fractions (Group B). Radiation-induced hepatic toxicity was defined as an increase of at least 2 points in the Child-Pugh score within 4 months of completing helical tomotherapy. We attempted to find the statistically significant parameters in the 2 groups using α/β ratios of 2, 4, 6, 8, or 10, and compared the estimated probability curves of each significant parameter. We hypothesized that the α/β ratio associated with the best matches for the curves between the 2 groups would be equivalent to the α/β ratio for the normal liver.

Results: When using an α/β ratio of 2 or 4, different parameters were found to be statistically significant in a multivariate analysis (Group A: VBED30 for α/β ratio=2 and VBED25 for α/β ratio=4, Group B: VBED25 for α/β ratio=2 and VBED20 for α/β ratio=4). When using an α/β ratio of 6, 8, or 10, VBED20 was found to be a statistically significant parameter in both groups. Comparison of the estimated probability curve of each significant parameter between the groups revealed that an α/β ratio of 8 resulted in the best matches.

Conclusions: We suggest that the α/β ratio of the normal liver with hepatitis is 8. We hope that previously reported parameters and their values can be effectively used in different fractionation schemes by calculating the biologically effective dose using an α/β ratio of 8.

Citing Articles

Managing hepatocellular carcinoma across the stages: efficacy and outcomes of stereotactic body radiotherapy : A retrospective study.

Mohamed A, Berres M, Bruners P, Lang S, Trautwein C, Wiltberger G Strahlenther Onkol. 2024; 200(8):715-724.

PMID: 38689147 PMC: 11272809. DOI: 10.1007/s00066-024-02235-5.

Characterization and Prediction of Signal Intensity Changes in Normal Liver Parenchyma on Gadoxetic Acid-enhanced MRI Scans after Liver-directed Radiation Therapy.

Nehlsen A, Sindhu K, Wolken T, Khan F, Kyriakakos C, Ward S Radiol Imaging Cancer. 2022; 4(4):e210100.

PMID: 35904411 PMC: 9358658. DOI: 10.1148/rycan.210100.

Test the Effectiveness of Quantitative Linear-Quadratic-Based (qLQB) Model on Evaluating Irradiation-Induced Liver Injury (ILI) Against Normal Tissue Complication Probability (NTCP).

Bai H, Wang L, Li W, Liu X, Xia Y, Chang L Dose Response. 2020; 18(3):1559325820961721.

PMID: 33013252 PMC: 7513411. DOI: 10.1177/1559325820961721.

Dose escalation in radiotherapy for incomplete transarterial chemoembolization of hepatocellular carcinoma.

Byun H, Kim H, Im Y, Kim D, Han K, Seong J Strahlenther Onkol. 2019; 196(2):132-141.

PMID: 31286149 DOI: 10.1007/s00066-019-01488-9.

Treatment Outcome after Fractionated Conformal Radiotherapy for Hepatocellular Carcinoma in Patients with Child-Pugh Classification B in Korea (KROG 16-05).

Bae S, Park H, Yoon W, Yoon S, Jung I, Lee I Cancer Res Treat. 2019; 51(4):1589-1599.

PMID: 30971065 PMC: 6790850. DOI: 10.4143/crt.2018.687.

References

Shim S, Seong J, Han K, Chon C, Suh C, Lee J . Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma. Liver Int. 2005; 25(6):1189-96. DOI: 10.1111/j.1478-3231.2005.01170.x. View

Seong J, Keum K, Han K, Lee D, Lee J, Chon C . Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 1999; 43(2):393-7. DOI: 10.1016/s0360-3016(98)00415-5. View

Liaw Y, Sung J, Chow W, Farrell G, Lee C, Yuen H . Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004; 351(15):1521-31. DOI: 10.1056/NEJMoa033364. View

Cheng J, Wu J, Huang C, Liu H, Huang D, Cheng S . Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication. Int J Radiat Oncol Biol Phys. 2002; 54(1):156-62. DOI: 10.1016/s0360-3016(02)02915-2. View

Cochrane A, Murray-Lyon I, BRINKLEY D, Williams R . Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma. Cancer. 1977; 40(2):609-14. DOI: 10.1002/1097-0142(197708)40:2<609::aid-cncr2820400203>3.0.co;2-l. View

Liang S, Huang X, Zhu X, Zhang W, Cai L, Huang H . Dosimetric predictor identification for radiation-induced liver disease after hypofractionated conformal radiotherapy for primary liver carcinoma patients with Child-Pugh Grade A cirrhosis. Radiother Oncol. 2010; 98(2):265-9. DOI: 10.1016/j.radonc.2010.10.014. View

Park W, Lim D, Paik S, Koh K, Choi M, Park C . Local radiotherapy for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2005; 61(4):1143-50. DOI: 10.1016/j.ijrobp.2004.08.028. View

Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H . Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 1985; 56(4):918-28. DOI: 10.1002/1097-0142(19850815)56:4<918::aid-cncr2820560437>3.0.co;2-e. View

Son S, Kay C, Song J, Lee S, Choi B, Kang Y . Dosimetric parameter predicting the deterioration of hepatic function after helical tomotherapy in patients with unresectable locally advanced hepatocellular carcinoma. Radiat Oncol. 2013; 8:11. PMC: 3552734. DOI: 10.1186/1748-717X-8-11. View

10.

Kim T, Kim D, Park J, Kim S, Choi J, Kim H . Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2006; 67(1):225-31. DOI: 10.1016/j.ijrobp.2006.08.015. View

11.

Liang S, Zhu X, Xu Z, Zhu J, Zhao J, Lu H . Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys. 2006; 65(2):426-34. DOI: 10.1016/j.ijrobp.2005.12.031. View

12.

Lewin K, Millis R . Human radiation hepatitis. A morphologic study with emphasis on the late changes. Arch Pathol. 1973; 96(1):21-6. View

13.

Lee I, Seong J, Shim S, Han K . Radiotherapeutic parameters predictive of liver complications induced by liver tumor radiotherapy. Int J Radiat Oncol Biol Phys. 2008; 73(1):154-8. DOI: 10.1016/j.ijrobp.2008.04.035. View

14.

Pan C, Kavanagh B, Dawson L, Li X, Das S, Miften M . Radiation-associated liver injury. Int J Radiat Oncol Biol Phys. 2010; 76(3 Suppl):S94-100. PMC: 4388033. DOI: 10.1016/j.ijrobp.2009.06.092. View

15.

Dawson L, Biersack M, Lockwood G, Eisbruch A, Lawrence T, Ten Haken R . Use of principal component analysis to evaluate the partial organ tolerance of normal tissues to radiation. Int J Radiat Oncol Biol Phys. 2005; 62(3):829-37. DOI: 10.1016/j.ijrobp.2004.11.013. View

16.

Dawson L, Normolle D, Balter J, McGinn C, Lawrence T, Ten Haken R . Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys. 2002; 53(4):810-21. DOI: 10.1016/s0360-3016(02)02846-8. View

17.

Son S, Choi B, Ryu M, Kang Y, Jang J, Bae S . Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication. Int J Radiat Oncol Biol Phys. 2010; 78(4):1073-80. DOI: 10.1016/j.ijrobp.2009.09.009. View

18.

Ogata K, Hizawa K, Yoshida M, KITAMURO T, AKAGI G, Kagawa K . HEPATIC INJURY FOLLOWING IRRADIATION--A MORPHOLOGIC STUDY--. Tokushima J Exp Med. 1963; 10:240-51. View

19.

Cheng J, Wu J, Chiao-Tzu Lee P, Liu H, Jian J, Lin Y . Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease. Int J Radiat Oncol Biol Phys. 2004; 60(5):1502-9. DOI: 10.1016/j.ijrobp.2004.05.048. View

20.

Lawrence T, Robertson J, Anscher M, Jirtle R, ENSMINGER W, Fajardo L . Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys. 1995; 31(5):1237-48. DOI: 10.1016/0360-3016(94)00418-K. View